Citations in PubMed

Primary Citation PubMed: 23217210 Citations in PubMed

PDB ID Mentions in PubMed Central Article count: 1

Citations in PubMed

This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.

PDB ID Mentions in PubMed Central

Data mentions are occurrences of PDB IDs in the full text articles from the PubMedCentral Open Access Subset of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed. Article titles can be filtered by keywords and sorted by year.

  • 3 per page
  • 5 per page
  • 10 per page
  • view all
  • Publication Year
  • Ascending
  • Descending

A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.

(2012) Retrovirology 9

PubMed: 23217210 | PubMedCentral: PMC3549755 | DOI: 10.1186/1742-4690-9-99

Models of complexes with 16 and 21 were based on the crystal structures presented in the current work (PDB IDs 4I2P and 4I2Q, respectively).

Table 1 X-ray data and refinement statistics   HIV-1 WT RT/16 K103N/Y181C mutant HIV-1 RT/21 Protein Data Bank (PDB) accession code 4I2P 4I2Q Space group C2 C2 Cell constants (a, b, c in Å; β in º) 162.65, 72.99, 109.50; 100.59 162.60, 72.95, 108.54; 100.70 Resolution range (Å) 50.00 – 2.30 50.00 – 2.70 Completeness (%) 98.8 99.2 R merge 0.085 0.084 Average I/σI 15.0 16.5 Sigma cut-off (I) |I| < −3.0σ |I| < −3.0σ Refinement Statistics Total no.

Publication Year: 2012